National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 
 
Results: 1 -10 of 22    Show     results per page
View Search Criteria | Help With Results
Title 
Phase sort ascending
Protocol IDs 
 
Effect of the Subconscious on Mohs Micrographic Surgery

   
No phase specified

   
1253-017
NCT00374062

 
 
Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Young Patients With Epidermolysis Bullosa at High Risk of Developing Squamous Cell Skin Cancer

   
No phase specified

   
UMN-MT2006-15
MT2006-15, UMN-0702M01504, NCT00478244

 
 
A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

   
No phase specified

   
WN07DE002
EudraCT No: 2007-001961-14, NCT00463359

 
 
Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

   
No phase specified

   
E.03.26007.1
NCT00515970

 
 
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

   
No phase specified

   
CASE-9Z07-CC417
CASE 9Z07-CC417, NCT00663910

 
 
Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)

   
No phase specified

   
P070158
NCT00699829

 
 
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

   
Phase I

   
CASE-CWRU-1Y04
CWRU-100301, NCT00103246, CASE-1Y04, CWRU1Y04, CASE1Y04

 
 
Photodynamic Therapy in Treating Patients With Skin Cancer

   
Phase II

   
RPCI-DS-96-55
NCI-G97-1224, NCT00002975

 
 
Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR

   
Phase II

   
2005-001098-82
NCT00240682

 
 
Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer

   
Phase II

   
NCI-06-C-0169
NCI-P6950, NCT00354055

 
      1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov